Back to search
FDAFDA · Food and drugs·Recall number Z-0968-2018

BD Vacutainer® K2 EDTA (K2E) 3.6mg Blood Collection Tube (13 x 75 mm x 2.0 mL). Catalog Number: 367841. Used for whole blood hematology determinations, immunohematology testing and blood donor screening.

Published March 21, 2018 · Recall initiated: August 29, 2017

Summary

FDA records medical device Class II recall Z-0968-2018, published March 21, 2018 and initiated August 29, 2017. Recalling firm: Becton Dickinson & Company; Status: Terminated; Reported quantity: 8,494,000; Lot: Catalog No. 367841 Lot No. 6279849 UDI: (01)30382903678410. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

A limited portion of the lot was manufactured with less than the required amount of K2EDTA additive, an anticoagulant, which may cause erroneous results that could lead to specimen recollection and potential delay of treatment or misdiagnosis/mismanagement of treatment and serious complications, such as failure to detect thrombocytosis or postponing surgery.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Becton Dickinson & Company
Distributor
Nationwide Distribution
Lot
Catalog No. 367841 Lot No. 6279849 UDI: (01)30382903678410
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was BD Vacutainer® K2 EDTA (K2E) 3.6mg Blood Collection Tube (13 x 75 mm x 2.0 mL). Catalog Number: 367841. Used for whole blood hematology determinations, immunohematology testing and blood donor screening. recalled?

Yes. FDA published recall Z-0968-2018 on March 21, 2018. Reported hazard: A limited portion of the lot was manufactured with less than the required amount of K2EDTA additive, an anticoagulant, which may cause erroneous results that could lead to specimen recollection and potential delay of treatment or misdiagnosis/mismanagement of treatment and serious complications, such as failure to detect thrombocytosis or postponing surgery.

What should I do if I have this product?

Voluntary: Firm initiated · Letter